PathNet: a tool for pathway analysis using topological information

BackgroundIdentification of canonical pathways through enrichment of differentially expressed genes in a given pathway is a widely used method for interpreting gene lists generated from high-throughput experimental studies. However, most algorithms treat pathways as sets of genes, disregarding any inter- and intra-pathway connectivity information, and do not provide insights beyond identifying lists of pathways.ResultsWe developed an algorithm (PathNet) that utilizes the connectivity information in canonical pathway descriptions to help identify study-relevant pathways and characterize non-obvious dependencies and connections among pathways using gene expression data. PathNet considers both the differential expression of genes and their pathway neighbors to strengthen the evidence that a pathway is implicated in the biological conditions characterizing the experiment. As an adjunct to this analysis, PathNet uses the connectivity of the differentially expressed genes among all pathways to score pathway contextual associations and statistically identify biological relations among pathways. In this study, we used PathNet to identify biologically relevant results in two Alzheimer’s disease microarray datasets, and compared its performance with existing methods. Importantly, PathNet identified de-regulation of the ubiquitin-mediated proteolysis pathway as an important component in Alzheimer’s disease progression, despite the absence of this pathway in the standard enrichment analyses.ConclusionsPathNet is a novel method for identifying enrichment and association between canonical pathways in the context of gene expression data. It takes into account topological information present in pathways to reveal biological information. PathNet is available as an R workspace image fromhttp://www.bhsai.org/downloads/pathnet/.

[1]  K. Honjo,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[2]  G. Dienel,et al.  Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice , 2010, ASN neuro.

[3]  R. Fisher,et al.  Statistical Methods for Research Workers , 1930, Nature.

[4]  James Lowe,et al.  Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders , 2003, Ageing Research Reviews.

[5]  Y. Zhong,et al.  PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila , 2010, Proceedings of the National Academy of Sciences.

[6]  Samuel L. Pfaff,et al.  Presenilin-Dependent Receptor Processing Is Required for Axon Guidance , 2011, Cell.

[7]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[8]  Geffrey F. Stopper,et al.  Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure , 2009, Genome Biology.

[9]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Roberto Malinow,et al.  Alzheimer's disease: Recollection of lost memories , 2011, Nature.

[11]  D. Salmon,et al.  Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[13]  George Perry,et al.  The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease , 2002, Neurosignals.

[14]  K. Honjo,et al.  Commentary on the letter for Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2010, Alzheimer's & Dementia.

[15]  Soheil Shams,et al.  Noise Sampling Method: An ANOVA Approach Allowing Robust Selection of Differentially Regulated Genes Measured by DNA Microarrays , 2003, Bioinform..

[16]  F. Lee,et al.  Neurotrophin signalling in health and disease. , 2006, Clinical science.

[17]  P. Penzes,et al.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease , 2011, Brain Research Reviews.

[18]  Morton B. Brown 400: A Method for Combining Non-Independent, One-Sided Tests of Significance , 1975 .

[19]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Arias,et al.  Inhibition of Wnt and PI3K Signaling Modulates GSK-3β Activity and Induces Morphological Changes in Cortical Neurons: Role of Tau Phosphorylation , 2008, Neurochemical Research.

[21]  H J Sagar Clinical similarities and differences between Alzheimer's disease and Parkinson's disease. , 1987, Journal of neural transmission. Supplementum.

[22]  Peter Bühlmann,et al.  Analyzing gene expression data in terms of gene sets: methodological issues , 2007, Bioinform..

[23]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[24]  Y. Gong,et al.  Abnormal cleavage of APP impairs its functions in cell adhesion and migration , 2009, Neuroscience Letters.

[25]  M. Kendall Statistical Methods for Research Workers , 1937, Nature.

[26]  Nicholas W. Wood,et al.  Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea , 2010, PLoS genetics.

[27]  Kentaro Abe,et al.  Synaptic contact dynamics controlled by cadherin and catenins. , 2005, Trends in cell biology.

[28]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[29]  Roland Eils,et al.  Group testing for pathway analysis improves comparability of different microarray datasets , 2006, Bioinform..

[30]  David A. Bennett,et al.  Is there a link between cancer and Alzheimer disease? , 2010, Neurology.

[31]  Chris T. A. Evelo,et al.  Exploring pathway interactions in insulin resistant mouse liver , 2011, BMC Systems Biology.

[32]  E. Grace,et al.  Aberrant Activation of Focal Adhesion Proteins Mediates Fibrillar Amyloid β-Induced Neuronal Dystrophy , 2003, The Journal of Neuroscience.

[33]  Sudarshan C Upadhya,et al.  Role of the ubiquitin proteasome system in Alzheimer's disease , 2007, BMC Biochemistry.

[34]  F. Yates,et al.  Statistical methods for research workers. 5th edition , 1935 .

[35]  Pankaj Agarwal,et al.  A global pathway crosstalk network , 2008, Bioinform..

[36]  C. Lendon,et al.  A common biological mechanism in cancer and Alzheimer's disease? , 2009, Current Alzheimer research.

[37]  George Perry,et al.  Evidence for the role of luteinizing hormone in Alzheimer disease. , 2007, Endocrine, metabolic & immune disorders drug targets.

[38]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[39]  Ronnie Driver,et al.  Biostatistics: a Methodology for the Health Sciences , 2005 .

[40]  R A Armstrong,et al.  Visual Field Defects in Alzheimer’s Disease Patients May Reflect Differential Pathology in the Primary Visual Cortex , 1996, Optometry and vision science : official publication of the American Academy of Optometry.

[41]  S. Oddo,et al.  The ubiquitin-proteasome system in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[42]  C. Giaume,et al.  Astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in β-amyloid precursor protein/presenilin1 mice , 2010, Neuroscience.

[43]  George Perry,et al.  Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. , 2006, Biochimica et biophysica acta.

[44]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[45]  Paul Greengard,et al.  Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61 , 2010, The Journal of Neuroscience.

[46]  M. Wozniak,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[47]  Sagar Hj,et al.  Clinical similarities and differences between Alzheimer's disease and Parkinson's disease. , 1987 .

[48]  Ramon C. Littell,et al.  Asymptotic Optimality of Fisher's Method of Combining Independent Tests , 1971 .

[49]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Richard L. Bowen,et al.  The gonadotropin connection in Alzheimer’s disease , 2005, Endocrine.

[51]  J. Pasquini,et al.  Defective ubiquitination of cerebral proteins in Alzheimer's disease , 2000, Journal of neuroscience research.

[52]  Zheng Jing,et al.  Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. , 2007, Biochimica et biophysica acta.

[53]  E. Coulson,et al.  Does the p75 neurotrophin receptor mediate Aβ‐induced toxicity in Alzheimer's disease? , 2006, Journal of neurochemistry.

[54]  C. Gondi,et al.  MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts. , 2009, International journal of oncology.

[55]  Zhi-Ping Liu,et al.  Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains , 2010, BMC Systems Biology.

[56]  P. Khatri,et al.  A systems biology approach for pathway level analysis. , 2007, Genome research.

[57]  N. Danbolt Glutamate uptake , 2001, Progress in Neurobiology.

[58]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[59]  S. Lehrer,et al.  Glioblastoma and dementia may share a common cause. , 2010, Medical hypotheses.

[60]  Eric M Reiman,et al.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. , 2007, Physiological genomics.

[61]  A. Alavi,et al.  Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease , 2003, Nuclear medicine communications.

[62]  Sandro Sorbi,et al.  Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease , 2007, Molecular medicine.

[63]  Qi Liu,et al.  BMC Bioinformatics BioMed Central Methodology article Comparative evaluation of gene-set analysis methods , 2007 .